Clinical Trial

Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL

Name: Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL — clinical trial record (NCT07106723)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To evaluate the safety and efficacy of autologous hematopoietic stem cell transfer (ASCT) combined with CD7-CART in the treatment of CD7+ TCL

Trial Details

NCT Number	NCT07106723
Lead Sponsor	Institute of Hematology & Blood Diseases Hospital, China Collaborators: Hebei Taihe Chunyu Biotechnology Co., Ltd
Conditions	CD7 Positive, T - Cell Lymphoma
Enrollment	50 participants
Start Date	2025-06-01
Primary Completion	2029-01-07 (estimated)
Study Completion	2030-01-07 (estimated)
Updated on ClinicalTrials.gov	2025-08-06